MassTort-National Product Liability

Jul 10, 2026

MassTort-National Talc Mesothelioma & Asbestos Toxic Tort Attorneys: Attorney911 Litigates Johnson & Johnson and the Talc Manufacturers Behind Asbestos-Contaminated Talcum Powder That Now Accounts for 40% of Mesothelioma Filings — Sharp Invisible Asbestos Fibers Ground Into Cosmetic Powder That Lodge in Cell Linings and Trigger the Mutations That Become Mesothelioma, We Secure Preserved Product Containers, Pathology Blocks and Corporate Internal Testing Records Before They Disappear, Ralph Manginello’s 27+ Years of Federal-Court Trial Practice, Lupe Peña the Former Insurance-Defense Insider, Strict Product Liability With the Limitations Clock Running From Diagnosis Under the Discovery Rule, the Firm Has Recovered $50M+ for Injury Victims & Millions in Wrongful-Death Cases — Free 24/7 Consultation, No Fee Unless We Win, Hablamos Español, 1-888-ATTY-911

Talc Now Blamed for Nearly Half of All Mesothelioma Lawsuits in 2025 If you are reading this page, someone you love has probably just heard a word no one is ever ready for — mesothelioma. Maybe you are the one who was diagnosed. Maybe it is your mother, your father, your spouse. You are sitting with a folder of medical records, a treatment plan you barely understand, and a question that is eating at you: how did this happen? You never worked in a refinery. You never installed insulation. You never served aboard a ship. You cannot point to a single day when you were “exposed to asbestos” at a job site. And then someone asks the question that changes everything: did you use talcum powder? Baby powder? Body powder? For years? For decades? And the answer is yes — and suddenly the diagnosis is not a mystery anymore. It is a product. We are Attorney911 — The Manginello Law Firm, PLLC. We are trial lawyers who handle toxic tort and catastrophic injury cases, and we are writing this page for the person at 2 a.m. who just connected the dots between a powder they trusted since childhood and a…

46 min read Read Article

Jul 10, 2026

Asbestos-Contaminated Talcum Powder & Ovarian Cancer Product Liability Claims — The Lancet Retracts a 1977 Safety Commentary After Historians Expose Johnson & Johnson’s Ghostwriting and Editorial Coordination That Helped Stave Off Federal Asbestos Regulation of Cosmetic Talc, Attorney911 Pursues the Manufacturer in MassTort-National Toxic Tort Litigation, We Secure the Corporate Discovery Memos, Letters and Draft Commentary Proving Decades of Concealed Contamination in Products Women Used Daily, Ralph Manginello’s 27+ Years of Federal-Court Trial Practice, Lupe Peña the Former Insurance-Defense Insider, Failure-to-Warn and Fraud-Based Punitive Damages Under Controlling Product Liability Doctrine, the Firm Has Recovered $50M+ for Injury Victims, the Statute of Limitations Is Running on Toxic Exposure Claims — Free 24/7 Consultation, No Fee Unless We Win, Hablamos Español, 1-888-ATTY-911

The Lancet Retracts a 1977 Talc Safety Commentary After Historians Expose Johnson & Johnson’s Ghostwriting — What This Means for Your Cancer Case If you are reading this, you or someone you love probably used talcum powder for years — maybe decades — and then heard the word cancer. Ovarian cancer. Mesothelioma. A diagnosis that arrived out of nowhere and rearranged everything. You may already be in a lawsuit. You may have watched a defense lawyer stand up in court and wave a 1977 commentary from one of the world’s oldest and most prestigious medical journals, claiming it proved talc was safe. Or you may be sitting at a kitchen table at 2 a.m., wondering whether it is too late to file. On March 25, 2026, The Lancet issued a rare retraction of that very commentary — disavowing it after public health historians uncovered evidence that the piece was not written by the journal’s editors at all. It was, according to the evidence the historians found in corporate records made public through court discovery, secretly authored by a consultant paid by Johnson & Johnson, one of the world’s leading producers of cosmetic talc products. The consultant shared an advance draft…

44 min read Read Article

Jul 10, 2026

MassTort-National Roundup Cancer Claims After the Supreme Court’s FIFRA Preemption Shield for Bayer — Warning-Label Theories Foreclosed but Design-Defect and Negligent-Testing Claims Survive: Attorney911 Pursues Monsanto’s Internal Research Records and Ghostwriting Evidence From MDL Discovery to Build Surviving Glyphosate Non-Hodgkin Lymphoma Cases, the IARC Probable-Carcinogen Finding Against the EPA’s Contrary Position Anchors General Causation Under Daubert, Ralph Manginello’s 27+ Years of Federal-Court Trial Practice, Lupe Peña the Former Insurance-Defense Insider Who Knows How the Claims Machine Values Toxic-Tort Inventories, the Firm Has Recovered $50M+ for Injury Victims, the Statute of Limitations Is Running on Surviving Claims — Free 24/7 Consultation, No Fee Unless We Win, Hablamos Español, 1-888-ATTY-911

You Just Heard the Supreme Court Ruled for Bayer — Here Is What That Actually Means for Your Roundup Cancer Case If you are reading this at 2 a.m., you probably saw the headline and felt the floor drop. You used Roundup for years — maybe on a farm, maybe on a landscaping crew, maybe just on your own property every weekend. Then the doctor said non-Hodgkin lymphoma. Then you heard there were lawsuits. Then a lawyer said you might have a case. And now the Supreme Court of the United States has ruled in favor of the company that made the product, and you think it is over. It is not over. Not for everyone. And the difference between “over” and “still alive” is something a lawyer who knows this litigation can tell you in one conversation. That is why we are writing this page — not to sell you anything, not to tell you your case is worth millions, but to give you the honest legal map of what just happened, what survives, and what you need to do right now if your case is one of the ones that can still move forward. We are Attorney911 —…

28 min read Read Article

Jul 10, 2026

Roundup Non-Hodgkin Lymphoma Product Liability Lawsuits After the Supreme Court’s 7-2 FIFRA Preemption Ruling: Attorney911 Pursues Bayer and Monsanto on the Surviving Negligence and Design-Defect Claims in the MassTort-National Litigation, Where the Glyphosate Cancer Causation Evidence the EPA Label Decision Never Addressed Becomes Central, Ralph Manginello’s 27+ Years of Federal-Court Trial Practice, We Secure Exposure Records, Purchase History and Internal Corporate Safety Research Before Spoliation, Lupe Peña the Former Insurance-Defense Insider Who Knows How Bayer’s Claims Machine Values and Denies Cancer Cases Against a $7.25 Billion Settlement Frame Where Some Claimants Could Receive as Little as $6,000, the Firm Has Recovered $50M+ for Injury Victims, the Statute of Limitations Is Running — Free 24/7 Consultation, No Fee Unless We Win, Hablamos Español, 1-888-ATTY-911

The Supreme Court Just Ruled on Roundup Lawsuits — Here’s What It Means for Your Non-Hodgkin Lymphoma Case You heard the news and your stomach dropped. The Supreme Court ruled against the Roundup failure-to-warn claims — the ones about cancer warnings on the label — and now you are sitting at your kitchen table at 2 a.m. wondering whether the case you were counting on just evaporated. We are going to tell you something that most of the coverage buried, missed, or got wrong: your legal options did not disappear. They changed shape. Failure-to-warn claims — the theory that the company should have put a cancer warning on the bottle — are now substantially foreclosed by federal preemption. But negligence claims and design-defect claims survived the ruling, law firms are still accepting and filing new cases, and the $7.25 billion settlement framework that Bayer is pushing may be grossly inadequate for people with serious non-Hodgkin lymphoma diagnoses. If you used Roundup and later developed this cancer, you need to understand what actually happened, what did not happen, and what your next move is — because the window to act under the most favorable remaining legal theories may narrow as lower…

39 min read Read Article

Jul 10, 2026

Roundup Glyphosate Cancer & Non-Hodgkin’s Lymphoma Product Liability Attorneys: For MassTort-National Claims Against Bayer AG and Monsanto, Attorney911 Builds Design-Defect and Fraud-on-the-Agency Theories That Survive FIFRA Preemption After the Supreme Court Shielded EPA-Approved Labels, Where 65,000+ Plaintiffs Allege Chronic Glyphosate Exposure Caused Their Cancer, Ralph Manginello’s 27+ Years of Federal-Court Trial Practice, Lupe Peña the Former Insurance-Defense Insider Who Knows How the Corporate Claims Machine Values and Denies Toxic-Tort Cases, We Secure Monsanto’s Internal Communications and the Retracted Safety Study Before the Evidence Degrades and Deadlines Run, the Firm Has Recovered $50M+ for Catastrophic Injury Victims — Free 24/7 Consultation, No Fee Unless We Win, Hablamos Español, 1-888-ATTY-911

Monsanto v. Durnell: The Supreme Court Preemption Ruling and What Survives for Your Roundup Cancer Case You just heard the news. The Supreme Court ruled against people who sued over Roundup. You have non-Hodgkin’s lymphoma. You used Roundup for years — on the farm, in the yard, on the job — and you believed the company when it said the product was safe. Now a 7-2 decision from the highest court in the country feels like it just locked the courthouse door in your face. Take a breath. The door is narrower than it was last month. It is not closed. The decision in Monsanto v. Durnell does eliminate many failure-to-warn claims — the theory that Monsanto should have put a cancer warning on the Roundup label and did not. But the Court did something the headlines missed: it left open entire categories of claims that do not depend on labeling at all. Design defect claims — that Roundup is unreasonably dangerous by its very formulation — may survive. Fraud claims — that Monsanto manipulated the science behind its safety classification — may survive. And the retraction of a decades-old study that Monsanto secretly helped shape has handed plaintiffs the…

44 min read Read Article

Jul 10, 2026

Roundup Non-Hodgkin Lymphoma & Toxic-Tort Attorneys: After the Supreme Court’s 7-2 Monsanto v. Durnell Ruling Preempted Failure-to-Warn Claims Under FIFRA, Attorney911 Pursues the Surviving Theories Against Bayer AG in MassTort-National Roundup Cancer Litigation, Design Defect, Fraudulent Concealment of Glyphosate’s Carcinogenicity, and Breach of Warranty, We Build on the 2022 Federal Court Ruling That Struck Down EPA’s Glyphosate Safety Determination as Unlawful, Ralph Manginello’s 27+ Years of Federal-Court Trial Practice, We Preserve Exposure Records, Purchase Receipts and Oncology Charts Before the Statute-of-Limitations Clock Runs on Tens of Thousands of Pending Cases, Lupe Peña the Former Insurance-Defense Insider Who Knows How Bayer’s Claims Machine Values and Denies These Cases, the Firm Has Recovered $50M+ for Injury Victims — Free 24/7 Consultation, No Fee Unless We Win, Hablamos Español, 1-888-ATTY-911

Roundup Cancer Lawsuits After the Supreme Court: What Monsanto v. Durnell Means for Your Case The news hit today and if you have non-Hodgkin lymphoma from Roundup, you may feel like the floor just dropped out. The Supreme Court ruled 7-2 that people who contract cancer from a pesticide cannot sue the manufacturer for failing to warn them — if the EPA did not require a cancer warning on the approved label. That sounds like the end of your case. It is not. Failure-to-warn was the strongest and most successful theory in the Roundup litigation. It produced verdicts. It drove the roughly $10 billion Bayer has already paid to settle approximately 100,000 cases. It is now preempted — blocked — by federal law for future failure-to-warn claims. But failure-to-warn was one theory, not the only theory. Design defect, fraudulent concealment, negligent testing, and breach of warranty claims target different duties — duties that do not depend on what the label says — and those claims may still survive. The generalist reads “failure-to-warn is preempted” and tells a client their case is over. The expert reads the same decision, sees four surviving paths, and starts building the case around them. We…

45 min read Read Article

Jul 10, 2026

MassTort-National Talc Powder Ovarian Cancer Product Liability Claims: Johnson & Johnson Faces 67,000+ Consolidated Lawsuits After a New Jersey Federal Court Disqualifies Lead Plaintiff Counsel, Attorney911 Brings Ralph Manginello’s 27+ Years of Federal-Court Trial Practice to Women Diagnosed With Ovarian Cancer From Talc-Based Body Powder, We Pursue the Manufacturer and Its Corporate Subsidiaries for Design Defect, Failure to Warn and Decades of Fraudulent Concealment, the Perineal Talc Exposure Pathway and Carcinogenic Inflammation Mechanism, We Secure J&J Internal Safety Testing Communications and Laboratory Records Before They Vanish, Lupe Peña the Former Insurance-Defense Insider Who Knows How Corporate Claims Teams Value and Deny Cancer Cases, the Firm Has Recovered Millions in Catastrophic Injury and Wrongful-Death Cases, FDA Cosmetic-Product Oversight and Products-Liability Doctrine, Your State’s Statute of Limitations Is Running — Free 24/7 Consultation, No Fee Unless We Win, Hablamos Español, 1-888-ATTY-911

The Talc Verdict Is Still Coming — What the Federal Court’s Disqualification Ruling Means for Your Ovarian Cancer Claim You just read the headline. A federal court kicked a major plaintiff firm off the biggest talc litigation in the country — more than 67,000 women’s claims against Johnson & Johnson, consolidated in a New Jersey federal courtroom, and the firm that was helping steer those cases has been barred from representing them. The ruling came down March 26, 2026, in a 41-page opinion that described a decade of litigation turned bitter and a collaboration that crossed an ethical line. If you are a woman who used talc-based body powder for years and was later diagnosed with ovarian cancer, that headline landed in your chest like a bad scan result. You are thinking: Does this mean my case is dead? Did the court just say the science was wrong? Did J&J win? No. No. And no. What the court did was punish a law firm for how it handled a specific ethical question — not question whether Johnson & Johnson’s talc caused cancer, not question whether the women’s claims are valid, and not dismiss a single plaintiff’s case. The underlying litigation…

43 min read Read Article

Jul 10, 2026

Roundup Cancer Lawsuit & Non-Hodgkin Lymphoma Attorneys — Attorney911 Pursues Bayer-Monsanto in the MassTort-National Roundup Product-Liability Litigation, $7.25 Billion Settlement Nears Approval as FIFRA Preemption Narrowed Failure-to-Warn but Design-Defect and Negligence Theories Survive the Supreme Court’s 7-2 Ruling, Ralph Manginello’s 27+ Years of Federal-Court Trial Practice, Lupe Peña the Former Insurance-Defense Insider, We Preserve Purchase Records, Pathology Reports and Internal Monsanto Corporate Documents Before They Disappear, the Firm Has Recovered $50M+ for Injury Victims — Free 24/7 Consultation, No Fee Unless We Win, Hablamos Español, 1-888-ATTY-911

The Supreme Court Ruled Against Roundup Plaintiffs — But Your Case Is Not Dead You heard the news. The Supreme Court ruled for Bayer in June 2026. Now you are sitting at a kitchen table or in a hospital waiting room, wondering whether the lawsuit you were counting on — or the settlement you were waiting for — just evaporated. The phone has been quiet. The lawyer you spoke to months ago may have called, or may not have. And the headline you read said something about preemption and warning labels, and you do not know what that means for the cancer in your body or the person you lost. Here is what we can tell you right now, before anything else: the litigation is not over. It is not winding down. There are roughly 61,000 active Roundup lawsuits still pending as of July 2026. Bayer has resolved more than 100,000 claims for approximately $11 billion, but the remaining cases — your case — are still very much alive. What the Supreme Court did was take away one legal theory. It did not take away your right to sue. It did not say Roundup is safe. It did not say…

39 min read Read Article

Jul 10, 2026

J&J Talc Baby Powder Ovarian Cancer Lawsuits: Johnson & Johnson Moves to Dismiss the MassTort-National MDL With Prejudice in the District of New Jersey After a Decade of Failure-to-Warn and Asbestos-Contamination Claims, Attorney911 Brings Ralph Manginello’s 27+ Years of Federal-Court Trial Practice to Talc Product Liability Cases, We Pursue the Manufacturer and Its Corporate Successor for Design Defect, Failure to Warn and Fraudulent Concealment, Lupe Peña the Former Insurance-Defense Insider Who Knows How the Corporate Claims Machine Values and Denies These Cases, We Preserve Product Containers With Lot Numbers, Pathology Reports and Internal Testing Documents Before They Disappear — J&J Discontinued Talc Baby Powder in North America, Making Remaining Samples Finite and Irreplaceable, Perineal Talc Exposure Classified as Possibly Carcinogenic Under IARC Standards While FDA Cosmetic Rules Left Safety Testing to the Manufacturer, the Firm Has Recovered $50M+ for Injury Victims and Millions in Wrongful-Death Cases, the Statute of Limitations Is Running — Free 24/7 Consultation, No Fee Unless We Win, Hablamos Español, 1-888-ATTY-911

J&J Talc Cancer MDL: What Johnson & Johnson’s Motion to Dismiss Means for Your Claim You used a product your whole life that was sold to you as safe — pure, gentle, meant for babies — and now you are sitting with an ovarian cancer diagnosis, or you are sitting where your mother used to sit, and she is gone. You heard that Johnson & Johnson just filed something in court that sounds like it could end everyone’s case at once. You are reading this at 2 a.m. because you cannot sleep, and you need to know whether your case — or your mother’s case — just disappeared. It did not. Here is what actually happened, what it means, and what you should do about it. We are Attorney911 — The Manginello Law Firm. Ralph Manginello has spent 27-plus years in courtrooms, including federal court, and before he was a lawyer he was a journalist, which means he reads a court filing and tells you what it actually says, not what someone wants you to hear. Lupe Peña sat on the other side of the table for years inside a national insurance-defense firm — the rooms where claims are valued,…

38 min read Read Article

Jul 10, 2026

Roundup Cancer Lawsuits After the Supreme Court’s 7-2 FIFRA Preemption Ruling: Attorney911, MassTort-National Product Liability and Toxic Tort Attorneys, Pursues Bayer AG and Monsanto Through Negligent Design and Corporate Suppression Claims That Survive the Decision — We Pull the Internal Communications, EPA Submissions and Suppressed Glyphosate Research Before Discovery Closes, Long-Term Herbicide Exposure Linked to Non-Hodgkin Lymphoma and Other Cancers, the Firm Has Recovered $50M+ for Injury Victims, Ralph Manginello’s 27+ Years of Federal-Court Trial Practice, Lupe Peña the Former Insurance-Defense Insider Who Knows How the Claims Machine Values and Denies Toxic Tort Cases, the Statute of Limitations Is Running Despite the Ruling — Free 24/7 Consultation, No Fee Unless We Win, Hablamos Español, 1-888-ATTY-911

The Supreme Court Ruled Against Roundup Warning Claims — Your Case Is Not Over You are a farmer. You have sprayed Roundup across your corn and soybean acres for years — maybe decades. You know the smell of it, the way the mist drifted on the days the wind turned, the feel of the sprayer handle in your hand through a full planting season. And now you have cancer. Non-Hodgkin lymphoma, maybe — the diagnosis that turned a routine doctor’s visit into a word you were not prepared to hear. You turned on the news on June 25, 2026, and the headline said the Supreme Court ruled for Bayer. Seven justices to two. Roundup users can no longer sue over missing cancer warnings. Your first thought was simple and cold: that is it. My case is over. It is not. And that is the single most important thing you need to hear right now. What the Supreme Court closed was one road — the failure-to-warn road, the argument that Bayer should have put a cancer warning on the label beyond what the EPA approved. What remains open are other roads: that the product itself was defectively designed, that Monsanto knew…

43 min read Read Article